Nahdi’s 9M profit slips to SAR 654.8M; Q3 at SAR 161.2M

Nahdi Medical Co.’s net profit declined to SAR 654.8 million for the first nine months of 2025, from SAR 662.9 million in the year-earlier period.

The company said profits were hurt by higher operating expenses (OPEX), driven by the company’s continued investment in its strategic initiatives — including new openings in the retail and healthcare services sectors, retail expansion in the UAE, and digital transformation. This impact was partially offset by ongoing operational efficiency measures.

Other post-operating income items rose by SAR 45.4 million, mainly due to higher interest expenses related to lease liabilities, reflecting the company’s efforts to accelerate business expansion.

Meanwhile, sales grew 7.6% year-on-year (YoY) in the nine-month period, aided by a solid performance in the retail business, in addition to robust contributions from the healthcare business, which grew by 79.4% and the UAE business which increased by 39.4%.

Gross profit increased by 8.1% YoY to reach SAR 2.85 billion, with gross profit margin rising by 20 bps to 37.4%. In addition, operating profit rose by 5.5% YoY to SAR 718.2 million.

Q3 2025 net profit stood at SAR 161.2 million, a decline of 11.5% YoY from SAR 182.2 million. 

Net profit for the third quarter of 2024 included a Zakat provision reversal of SAR 32.7 million. Excluding this impact, the adjusted net profit growth would reach 8.0%. On the other hand, revenues grew by 4.6% YoY. 

On a sequential basis, net earnings decreased by 32.4% from SAR 238.4 million, as sales dropped by 2.6% quarter-on-quarter. 

Attached Documents

View More Financial Results